| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1980 | |
| Phytochemical name or plant extracts | Maytansinoids | |
| PMID | 27521896 | |
| Literature evidence | On the one hand, the fragmentation pathways of the maytansinoids we report herein using HRMS(n) will allow quick identification of these compounds in the future without isolating from the natural resources. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Ansamycin | |
| Source of phytochemicals or plant Extracts | Putterlickia pyracantha | |
| Geographical availability | Cape Provinces | |
| Plant parts | NA | |
| Other cancers | Breast cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | Maytansinoids possess remarkable antibiotic activities along with high cytotoxicity, many of which are currently used (or in clinical trials) in the treatment of breast cancer. | |
| Cell line/ mice model | NA | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:162449-1 | |
| Safety | NA |